Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 8
Submit an article Journal homepage
1,305
Views
8
CrossRef citations to date
0
Altmetric
Point of View

Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses

Denarda Dangaj Department of Oncology; Ludwig Cancer Research Center; University of Lausanne; Lausanne, Switzerland
&
Nathalie Scholler SRI International; Center for Cancer and Metabolism; Biosciences Division; Menlo Park, CA USACorrespondence[email protected]
Article: e25913 | Received 25 Jul 2013, Accepted 26 Jul 2013, Published online: 31 Jul 2013

References

  • Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348:203 - 13; http://dx.doi.org/10.1056/NEJMoa020177; PMID: 12529460
  • Torres MP, Ponnusamy MP, Lakshmanan I, Batra SK. Immunopathogenesis of ovarian cancer. Minerva Med 2009; 100:385 - 400; PMID: 19910891
  • Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, Zou W. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007; 67:8900 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-07-1866; PMID: 17875732
  • Wei J, Loke P, Zang X, Allison JP. Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity. J Exp Med 2011; 208:1683 - 94; http://dx.doi.org/10.1084/jem.20100639; PMID: 21727190
  • Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S, Kong B. B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer 2009; 19:1481 - 6; http://dx.doi.org/10.1111/IGC.0b013e3181ad0fa2; PMID: 19955922
  • Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203:871 - 81; http://dx.doi.org/10.1084/jem.20050930; PMID: 16606666
  • Dangaj D, Lanitis E, Zhao A, Joshi S, Cheng Y, Sandaltzopoulos R, Ra HJ, Danet-Desnoyers G, Powell DJ Jr., Scholler N. Novel recombinant human B7-H4 antibodies overcome tumoral immune escape to potentiate T cell anti-tumor responses. Cancer Res 2013; Forthcoming http://dx.doi.org/10.1158/0008-5472.CAN-12-3457; PMID: 23722540
  • Chen C, Qu QX, Shen Y, Mu CY, Zhu YB, Zhang XG, Huang JA. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape. Cancer Lett 2012; 317:99 - 105; http://dx.doi.org/10.1016/j.canlet.2011.11.017; PMID: 22108530
  • Zhang L, Wu H, Lu D, Li G, Sun C, Song H, Li J, Zhai T, Huang L, Hou C, et al. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus. Oncogene 2013; Forthcoming http://dx.doi.org/10.1038/onc.2012.600; PMID: 23318460
  • Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, Segal NH, Ariyan CE, Gordon RA, Reed K, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med 2013; 369:122 - 33; http://dx.doi.org/10.1056/NEJMoa1302369; PMID: 23724867

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.